Ghosn J - Search Results

1

Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study.

Cuzin L, Trabelsi S, Delobel P, Barbuat C, Reynes J, Allavena C, Peytavin G, Ghosn J, Lascoux-Combe C, Psomas C, Corbeau P, Flandre P; ANRS 145 MARIMUNO Study group. Cuzin L, et al. Among authors: ghosn j. J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):557-64. doi: 10.1097/QAI.0b013e318273015f. J Acquir Immune Defic Syndr. 2012. PMID: 22986949 Clinical Trial.

2

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.

Ghosn J, Lamotte C, Ait-Mohand H, Wirden M, Agher R, Schneider L, Bricaire F, Duvivier C, Calvez V, Peytavin G, Katlama C. Ghosn J, et al. AIDS. 2003 Jan 24;17(2):209-14. doi: 10.1097/00002030-200301240-00011. AIDS. 2003. PMID: 12545081 Clinical Trial.

3

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

Duvivier C, Myrto A, Marcelin AG, Ghosn J, Ait-Mohand H, Schneider L, Agher R, Bricaire F, Costagliola D, Calvez V, Peytavin G, Katlama C. Duvivier C, et al. Among authors: ghosn j. Antivir Ther. 2003 Dec;8(6):603-9. Antivir Ther. 2003. PMID: 14760894

4

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.

Wirden M, Marcelin AG, Tubiana R, Valantin MA, Ghosn J, Duvivier C, Dominguez S, Paris L, Agher R, Peytavin G, Katlama C, Calvez V. Wirden M, et al. Among authors: ghosn j. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):876-8. doi: 10.1097/00126334-200407010-00016. J Acquir Immune Defic Syndr. 2004. PMID: 15213573 No abstract available.

5

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

Ghosn J, Chaix ML, Peytavin G, Rey E, Bresson JL, Goujard C, Katlama C, Viard JP, Tréluyer JM, Rouzioux C. Ghosn J, et al. AIDS. 2004 Sep 24;18(14):1958-61. doi: 10.1097/00002030-200409240-00014. AIDS. 2004. PMID: 15353984

6

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.

Ghosn J, Wirden M, Ktorza N, Peytavin G, Aït-Mohand H, Schneider L, Dominguez S, Bricaire F, Calvez V, Costagliola D, Katlama C. Ghosn J, et al. AIDS. 2005 Oct 14;19(15):1643-7. doi: 10.1097/01.aids.0000181322.17679.b2. AIDS. 2005. PMID: 16184034 Clinical Trial.

7

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, Katlama C. Dominguez S, et al. Among authors: ghosn j. AIDS. 2006 May 12;20(8):1157-61. doi: 10.1097/01.aids.0000226956.02719.fd. AIDS. 2006. PMID: 16691067 Review.

8

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.

Dominguez S, Ghosn J, Peytavin G, Izzedine H, Wirden M, Ktorza N, Miller M, Aubron-Olivier C, Trylesinski A, Calvez V, Deray G, Katlama C. Dominguez S, et al. Among authors: ghosn j. J Med Virol. 2007 Feb;79(2):105-10. doi: 10.1002/jmv.20769. J Med Virol. 2007. PMID: 17177308 Clinical Trial.

9

Post-exposure prophylaxis with a maraviroc-containing regimen after occupational exposure to a multi-resistant HIV-infected source person.

Méchai F, Quertainmont Y, Sahali S, Delfraissy JF, Ghosn J. Méchai F, et al. Among authors: ghosn j. J Med Virol. 2008 Jan;80(1):9-10. doi: 10.1002/jmv.21000. J Med Virol. 2008. PMID: 18041046

10

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.

Delfraissy JF, Flandre P, Delaugerre C, Ghosn J, Horban A, Girard PM, Norton M, Rouzioux C, Taburet AM, Cohen-Codar I, Van PN, Chauvin JP. Delfraissy JF, et al. Among authors: ghosn j. AIDS. 2008 Jan 30;22(3):385-93. doi: 10.1097/QAD.0b013e3282f3f16d. AIDS. 2008. PMID: 18195565 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters